Anti-MARK 1+2+3+4 (phospho T215) antibody (ab111437)

Overview

  • Product nameAnti-MARK 1+2+3+4 (phospho T215) antibody
    See all MARK 1+2+3+4 primary antibodies
  • Description
    Rabbit polyclonal to MARK 1+2+3+4 (phospho T215)
  • Specificityab111437 detects endogenous levels of MARK 1+2+3+4 only when phosphorylated at threonine 215 (Human: Thr215/208/235/215; Mouse: Thr215/208/212/215; Rat: Thr215/208/212/-).
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat
  • Immunogen

    Synthetic phosphopeptide derived from Human MARK 1+2+3+4 around the phosphorylation site of threonine 215 (L-D-TP-F-C).

  • Positive control
    • Human breast carcinoma tissue

Properties

Applications

Our Abpromise guarantee covers the use of ab111437 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Target

Anti-MARK 1+2+3+4 (phospho T215) antibody images

  • ab111437, at 1/50 dilution, staining MARK 1+2+3+4 in paraffin-embedded Human breast carcinoma tissue by Immunohistochemistry, in the presence (right panel) or absence (left panel) of immunising peptide.

References for Anti-MARK 1+2+3+4 (phospho T215) antibody (ab111437)

ab111437 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab111437.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"